Drug intelligence / Profile preview

compound honeysuckle granules

Development stage
Unknown
Lead developer
Guangzhou Nuojin Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Compound Honeysuckle Granules is a traditional Chinese medicine (TCM) over-the-counter (OTC) oral preparation developed and manufactured by Guangzhou Nuojin Pharmaceutical. Formulated as granules for oral administration, this preparation is a compound mixture typically derived from the extracts of *Lonicera japonica* (Honeysuckle), *Forsythia suspensa*, and *Scutellaria baicalensis*. In the context of traditional Chinese medicine, it is primarily indicated for clearing heat and detoxifying (Qingre Jiedu), which clinically translates to the treatment of wind-heat type common colds, sore throats, and inflammatory conditions such as boils and swelling. The therapeutic efficacy is attributed to the synergistic effects of its herbal constituents, which exhibit anti-inflammatory, antibacterial, and antiviral properties. The product is approved and marketed in China for these indications.

Brand names
Nuojin
Other names
Fufang Jinyinhua KeliCompound Honeysuckle Granules
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on compound honeysuckle granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound honeysuckle granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call